These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 16098652)
1. Medical management of incidents with chemical warfare agents. Zilker T Toxicology; 2005 Oct; 214(3):221-31. PubMed ID: 16098652 [TBL] [Abstract][Full Text] [Related]
2. Combined chemical and conventional injuries--pathophysiological, diagnostic and therapeutic aspects. Berkenstadt H; Marganitt B; Atsmon J Isr J Med Sci; 1991; 27(11-12):623-6. PubMed ID: 1757234 [TBL] [Abstract][Full Text] [Related]
3. Toxicological aspects of preparedness and aftercare for chemical-incidents. Schwenk M; Kluge S; Jaroni H Toxicology; 2005 Oct; 214(3):232-48. PubMed ID: 16118031 [TBL] [Abstract][Full Text] [Related]
4. Chemical warfare agents. Kuca K; Pohanka M EXS; 2010; 100():543-58. PubMed ID: 20358695 [TBL] [Abstract][Full Text] [Related]
5. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Balali-Mood M; Hefazi M Fundam Clin Pharmacol; 2005 Jun; 19(3):297-315. PubMed ID: 15910653 [TBL] [Abstract][Full Text] [Related]
7. Role of the emergency physician in treatment of the poisoned patient. Guzzardi LJ Emerg Med Clin North Am; 1984 Feb; 2(1):3-13. PubMed ID: 6519022 [TBL] [Abstract][Full Text] [Related]
8. Treatment of Iranian soldiers attacked by chemical and microbiological war gases. Heyndrickx A; Heyndrickx B Arch Belg; 1984; Suppl():57-9. PubMed ID: 6535497 [No Abstract] [Full Text] [Related]
9. Mass casualty chemical exposure and implications for respiratory failure. Muskat PC Respir Care; 2008 Jan; 53(1):58-63; discussion 63-6. PubMed ID: 18173860 [TBL] [Abstract][Full Text] [Related]
10. [Nerve paralytic agents--the greatest threat for mass poisoning during chemical warfare or terrorist attacks]. Kassa J Cas Lek Cesk; 2001 Dec; 140(24):745-51. PubMed ID: 14655276 [TBL] [Abstract][Full Text] [Related]
11. Antidotes and treatments for chemical warfare/terrorism agents: an evidence-based review. Rodgers GC; Condurache CT Clin Pharmacol Ther; 2010 Sep; 88(3):318-27. PubMed ID: 20686476 [TBL] [Abstract][Full Text] [Related]
12. Development of antidotes: problems and strategies. Szinicz L; Worek F; Thiermann H; Kehe K; Eckert S; Eyer P Toxicology; 2007 Apr; 233(1-3):23-30. PubMed ID: 16949190 [TBL] [Abstract][Full Text] [Related]
13. Chemical warfare issues. Hollinger M Crit Care Nurse; 2004 Feb; 24(1):14; author reply 14. PubMed ID: 15007887 [No Abstract] [Full Text] [Related]
14. [Principles of the prevention and treatment of lesions from toxic agents]. Polumiskov IuM; Cherniak SI Voen Med Zh; 1975 Aug; (8):15-8. PubMed ID: 1179660 [No Abstract] [Full Text] [Related]
15. Old antidotes, new antidotes, and a 'universal antidote': what should we be using for pediatric poisoning? Liebelt EL Curr Opin Pediatr; 2007 Apr; 19(2):199-200. PubMed ID: 17496765 [No Abstract] [Full Text] [Related]
16. Aerosolized atropine as an antidote to nerve gas. Orma PS; Middleton RK Ann Pharmacother; 1992; 26(7-8):937-8. PubMed ID: 1504407 [No Abstract] [Full Text] [Related]
17. [In-hospital management of victims of chemical weapons of mass destruction]. Barelli A; Gargano F; Proietti R Ann Ist Super Sanita; 2005; 41(1):93-101. PubMed ID: 16037657 [TBL] [Abstract][Full Text] [Related]
20. [Nerve gas--guidelines for care of victims of terrorism]. Aas P; Jacobsen D Tidsskr Nor Laegeforen; 2005 Mar; 125(6):731-5. PubMed ID: 15776066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]